IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 304 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,971 | -1.6% | 308 | -11.0% | 0.00% | 0.0% |
Q2 2023 | $14,196 | +65.5% | 346 | +44.2% | 0.00% | +100.0% |
Q1 2023 | $8,578 | +97.5% | 240 | +108.7% | 0.00% | 0.0% |
Q4 2022 | $4,344 | -45.7% | 115 | -37.2% | 0.00% | 0.0% |
Q3 2022 | $8,000 | +300.0% | 183 | +221.1% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 57 | +185.0% | 0.00% | – |
Q4 2021 | $1,000 | -66.7% | 20 | -80.4% | 0.00% | -100.0% |
Q3 2021 | $3,000 | +200.0% | 102 | +537.5% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 16 | -65.2% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 46 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $3,000 | – | 46 | – | 0.00% | – |
Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 20 | -54.5% | 0.00% | -100.0% |
Q2 2019 | $2,000 | -33.3% | 44 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $3,000 | +50.0% | 44 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | – | 44 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |